Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...
Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.
Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...
Scanning a protein sequence database for the region, the researchers saw that the lncRNA contained a sORF that was highly conserved in mice and rats. In humans, it appears to be translated into a ...
Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long ...
Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.
NORAD is a unique molecule from the lncRNA group, a group of non-coding RNA molecules. While many RNA molecules serve as intermediates in the protein synthesis pathway based on genetic code ...